ChronoScale Corporation (CHRN) Stock Forecast
CHRN analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 5.00 / 5 from 1 analysts
- Price target
- $28.50 average of analyst targets
- Upside to target
- +89.0% from the latest close
- Next earnings
- —
- 52-week range
- $3.87 – $29.63
CHRN analyst ratings
1 analystsNumber of analysts at each rating.
CHRN price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
CHRN earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Nov '26) | −$0.13 | −$0.19 | −$0.07 | — | — | 2 |
| Next quarter (Feb '27) | −$0.12 | −$0.15 | −$0.10 | — | — | 2 |
| Current fiscal year (FY2027) | −$0.49 | −$0.59 | −$0.39 | — | — | 2 |
| Next fiscal year (FY2028) | $0.17 | −$0.15 | $0.50 | −$0.49 | +135.7% | 2 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
CHRN revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Nov '26) | $18.3M | $18.1M | $18.5M | — | 2 |
| Next quarter (Feb '27) | $25.6M | $18.5M | $32.7M | — | 2 |
| Current fiscal year (FY2027) | $138.7M | $132.3M | $145.0M | — | 2 |
| Next fiscal year (FY2028) | $947.8M | $930.2M | $965.3M | +583.6% | 2 |
CHRN EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
CHRN revenue: reported and forecast
CHRN EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Nov '26) | $0.00 | $0.00 | $0.00 | −$0.08 | −$0.13 | — | 0 up · 0 down |
| Next quarter (Feb '27) | $0.00 | $0.00 | $0.00 | −$0.12 | −$0.12 | — | 0 up · 0 down |
| Current fiscal year (FY2027) | $0.00 | $0.00 | $0.00 | −$0.42 | −$0.49 | — | 0 up · 0 down |
| Next fiscal year (FY2028) | $0.00 | $0.00 | $0.00 | −$0.22 | $0.17 | — | 0 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
CHRN earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; CHRN beat in 0 of 2.
What analysts expect from CHRN
1 analysts cover ChronoScale; their consensus rating is strong buy (5.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $28.50, 89.0% above the latest close of $15.08. Analysts expect earnings of −$0.49 per share for FY2027. For FY2028 the average estimate is $0.17 per share on revenue of $947.8 million. ChronoScale beat the EPS estimate in 0 of the last 2 quarters.
Related: CHRN income statement, CHRN key metrics, CHRN chart. See the CHRN stock overview for the latest quote and news.
CHRN forecast FAQ
What is ChronoScale's price target?
The average analyst price target for ChronoScale is $28.50, 89.0% above the latest close of $15.08.
Is ChronoScale a buy, hold or sell?
Of 1 analysts covering ChronoScale, 1 rate it a strong buy, 0 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is ChronoScale's EPS forecast?
Analysts forecast −$0.49 per share for FY2027 (range −$0.59 to −$0.39); for FY2028 the estimate is $0.17.
What is ChronoScale's revenue forecast?
The average revenue estimate for FY2027 is $138.7 million; for FY2028 it is $947.8 million.
Does ChronoScale usually beat earnings estimates?
ChronoScale reported EPS at or above the analyst estimate in 0 of the last 2 quarters.